Correlation Between Xtrackers ShortDAX and Arrowhead Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Xtrackers ShortDAX and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xtrackers ShortDAX and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Xtrackers ShortDAX and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Xtrackers ShortDAX and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xtrackers ShortDAX with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xtrackers ShortDAX and Arrowhead Pharmaceuticals.

Diversification Opportunities for Xtrackers ShortDAX and Arrowhead Pharmaceuticals

-0.54

Correlation Coefficient

Xtrackers ShortDAX  Arrowhead Pharmaceuticals

Excellent diversification

The 3 months correlation between Xtrackers and Arrowhead is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Xtrackers ShortDAX and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Xtrackers ShortDAX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xtrackers ShortDAX are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Xtrackers ShortDAX i.e., Xtrackers ShortDAX and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between Xtrackers ShortDAX and Arrowhead Pharmaceuticals

Assuming the 90 days trading horizon Xtrackers ShortDAX is expected to under-perform the Arrowhead Pharmaceuticals. But the etf apears to be less risky and, when comparing its historical volatility, Xtrackers ShortDAX is 2.79 times less risky than Arrowhead Pharmaceuticals. The etf trades about -0.08 of its potential returns per unit of risk. The Arrowhead Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,778  in Arrowhead Pharmaceuticals on September 19, 2024 and sell it today you would lose (668.00) from holding Arrowhead Pharmaceuticals or give up 24.05% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.6%
Values	Daily Returns

Xtrackers ShortDAX  vs.  Arrowhead Pharmaceuticals

Xtrackers ShortDAX

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Xtrackers ShortDAX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Etf's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the Exchange Traded Fund stockholders.

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Xtrackers ShortDAX and Arrowhead Pharmaceuticals

The main advantage of trading using opposite Xtrackers ShortDAX and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xtrackers ShortDAX position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.

The idea behind Xtrackers ShortDAX and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.